This company has been marked as potentially delisted and may not be actively trading. Eaton Vance Ohio Municipal Income Trust (EVO) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock EVO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Eaton Vance Short Duration Municipal Income ETF declares $0.1352 dividendApril 1, 2025 | msn.comEaton Vance Intermediate Municipal Income ETF declares $0.1714 dividendApril 1, 2025 | msn.comEaton Vance SC Municipal Income CMarch 20, 2025 | morningstar.comMEaton Vance MA Municipal Income IOctober 4, 2024 | morningstar.comMHow is JD Vance connected to the Project 2025 plan to tear apart federal government, and democracy? Today in OhioAugust 13, 2024 | msn.comHow JD Vance's Ohio hometown defied his expectationsJuly 27, 2024 | reuters.comEvotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington’s DiseaseMay 28, 2024 | finance.yahoo.comBayer and Evotec Collaborate to Advance Precision CardiologyApril 30, 2024 | finance.yahoo.comEvotec welcomes Aurélie Dalbiez as Chief People OfficerApril 17, 2024 | finance.yahoo.comEvotec (ETR:EVT shareholders incur further losses as stock declines 3.7% this week, taking three-year losses to 59%March 18, 2024 | finance.yahoo.comEvotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD TherapiesJanuary 10, 2024 | finance.yahoo.comEvotec-partner Jingxin Receives Approval for EVT201 in ChinaDecember 6, 2023 | finance.yahoo.comEvotec SE's (ETR:EVT) largest shareholders are individual investors with 47% ownership, institutions own 34%December 4, 2023 | finance.yahoo.comEvotec Presents Precision Medicine Platforms for Accelerated Pipeline Building at Capital Markets DayNovember 15, 2023 | finance.yahoo.comDewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology PipelineNovember 7, 2023 | finance.yahoo.comEvotec and Dewpoint Therapeutics Enter Strategic Partnership in OncologyNovember 7, 2023 | finance.yahoo.comEvotec SE Reports Results for the First Half-year 2023 and Provides Corporate UpdatesAugust 29, 2023 | finance.yahoo.comETX Eaton Vance Municipal Income 2028 Term TrustAugust 24, 2023 | seekingalpha.comEvotec SE Reports First Half-Year 2023 Results on 29 August 2023August 22, 2023 | finance.yahoo.comEvotec Provides Update on Financial Impact of Cyber-AttackJuly 28, 2023 | finance.yahoo.comEvotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience PartnershipJuly 11, 2023 | finance.yahoo.comJust - Evotec Biologics Awarded Second Contract from U.S. Department of Defense Under Accelerated Antibodies ProgramJuly 5, 2023 | finance.yahoo.comEvotec Receives Milestone Payment for First Patient Dosed in Phase I Study of Bayer Kidney Disease ProgrammeJune 29, 2023 | finance.yahoo.comUPDATE 1-European shares dip on rate jitters, banks riseJune 8, 2023 | finance.yahoo.comEvotec Presents Sustainability StrategyJune 5, 2023 | finance.yahoo.comEvotec publishes Annual Report 2022 and Quarterly Statement for Q1 2023May 12, 2023 | finance.yahoo.comJust - Evotec Biologics Enters Strategic Biosimilars Partnership with SandozMay 9, 2023 | finance.yahoo.comSuccessful Results Using Sernova’s Cell Pouch System™ with Evotec’s iPSC-Derived Islet-like Clusters for Type 1 Diabetes Presented at the 4th IPITA / HSCI / JDRF SummitApril 24, 2023 | finance.yahoo.comEvotec (ETR:EVT) pulls back 5.0% this week, but still delivers shareholders notable 6.1% CAGR over 5 yearsApril 17, 2023 | finance.yahoo.comCyber Attack on EvotecApril 7, 2023 | finance.yahoo.comEvotec SE to Announce Preliminary Financial Results for Fiscal Year 2022 on 28 March 2023March 21, 2023 | finance.yahoo.comEvotec Receives € 150 m Loan from European Investment BankFebruary 10, 2023 | finance.yahoo.comEvotec Announces Agreement with Janssen to Develop Immune-Based TherapiesJanuary 26, 2023 | finance.yahoo.comEaton Vance National Municipal Income CJanuary 21, 2023 | morningstar.comMEaton Vance SC Municipal Income AJanuary 14, 2023 | morningstar.comMSernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 DiabetesJanuary 10, 2023 | finance.yahoo.comDoes Evotec SE (EVO) Have Good Long-Term Growth Prospects?December 21, 2022 | finance.yahoo.com8% Yield Via This Leveraged Loan CEF From Eaton VanceNovember 26, 2022 | seekingalpha.comInvestors in Evotec (ETR:EVT) have unfortunately lost 53% over the last yearNovember 8, 2022 | finance.yahoo.comEvotec Enters Partnership with Hannover Medical School to Create Molecular Patient Database in Autoimmune DiseasesOctober 25, 2022 | finance.yahoo.comEvotec launches PanOmics Data Analysis Platform PanHunter at Bio-IT WorldOctober 18, 2022 | finance.yahoo.comAdapsyn Bioscience Inks Collaboration Pact With EvotecSeptember 21, 2022 | finance.yahoo.comEvotec Initiates Ground-Breaking for New Biologics Facility J.POD(R) Toulouse, France (EU)September 16, 2022 | finance.yahoo.comEvotec Expands Clinical and Commercial Drug Substance Manufacturing with Acquisition of Central Glass GermanyAugust 25, 2022 | finance.yahoo.comJust - Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303August 10, 2022 | finance.yahoo.comEvotec SE Reports Results of Annual General Meeting 2022June 22, 2022 | finance.yahoo.comEvotec (EVO) Inks Drug Discovery Collaboration Deal With J&JJune 15, 2022 | finance.yahoo.comExscientia -Evotec Cancer Therapy Shows Encouraging Action In Healthy VolunteersJune 14, 2022 | finance.yahoo.comEvotec Enters a Drug Discovery Collaboration with JanssenJune 14, 2022 | finance.yahoo.comEvotec and Almirall Enter into a Multi-Target Alliance in Medical DermatologyMay 19, 2022 | finance.yahoo.com Get Eaton Vance Ohio Municipal Income Trust News Delivered to You Automatically Sign up to receive the latest news and ratings for EVO and its competitors with MarketBeat's FREE daily newsletter. Email Address EVO Media Mentions By Week EVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVO News Sentiment▼0.001.01▲Average Medical News Sentiment EVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVO Articles This Week▼00▲EVO Articles Average Week Get Eaton Vance Ohio Municipal Income Trust News Delivered to You Automatically Sign up to receive the latest news and ratings for EVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MorphoSys News Today Evotec News Today Calliditas Therapeutics AB (publ) News Today Zymeworks News Today Chimerix News Today MBX Biosciences News Today Checkpoint Therapeutics News Today Aerovate Therapeutics News Today Mawson Infrastructure Group News Today 2seventy bio News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:EVO) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eaton Vance Ohio Municipal Income Trust Please log in to your account or sign up in order to add this asset to your watchlist. Share Eaton Vance Ohio Municipal Income Trust With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EVO Stock Alerts